Life Sciences In Action Podcast: Interview with Brad Brown, CEO of ATL Technologies on Tariffs, Manufacturing Overseas, Quality and More
January 17, 2019
The recent tariffs placed on imports have complicated the manufacturing and distribution processes for any life sciences company doing business overseas. In the pilot episode of the Life Scienes in Action Podcast Series, BioUtah president and CEO, Kelvyn Cullimore, interviews Brad Brown, CEO and chairman of ATL Technology, to discuss how the tarriffs have impacted their business. Other topics discussed include:
- Factors influencing overseas manufacturing
- The importance of quality in the manufacturing process
- Vertical integration of the manufacturing process
- What to look for when selecting a medical device manufacturer
- The importance of life sciences companies participating in BioUtah
Recent News
- BioUtah’s 2026 Utah Life Sciences Summit Recap
- 2026 Life Sciences Awards to be Presented at the Mayer Brown Utah Life Sciences Summit
- PROGRESS TRIAL DEMONSTRATES EDWARDS TAVR IS SUPERIOR TO CLINICAL SURVEILLANCE FOR MODERATE AS PATIENTS WITH AT-RISK FEATURES
- Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
- Utah Business, Government Leaders Deepen Connections in Ireland
- Co-Diagnostics’ Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara’s SARAGENE® Test
